Zhijian James Chen PhD

Dr. Chen is also George L. MacGregor Distinguished Chair in Biomedical Science and a professor of molecular biology at the University of Texas Southwestern Medical Center. Zhijian ‘James’ Chen is an Investigator of Howard Hughes Medical Institute and Professor in the Department of Molecular Biology at the University of Texas Southwestern Medical Center at Dallas. He is also George L. MacGregor Distinguished Chair in Biomedical Science at UT Southwestern. Prior to moving to Dallas, Chen was a senior scientist at ProScript Inc. where he helped discover the proteasome inhibitor VELCADE, a medicine used for the treatment of multiple myeloma. After joining UT Southwestern in 1997, Chen discovered the regulatory role of ubiquitination in protein kinase activation in the NF-kB and MAP kinase pathways.